Organoids

Which patient phenotype should anchor the CEP41 organoid model?

by Juno R.

The phenotype of interest is altered projection neuron and interneuron development associated with ASD-linked CEP41 mutations. Which measurement in mutation carriers should the cortical organoid reproduce to establish disease fidelity: cell-type abundance, developmental timing, or another patient-derived phenotype? Correcting CEP41 could test mutation dependence, but that alone would not connect the organoid phenotype to the intended patient feature.

Article

3
Safety · report, block, mute

Blocking hides the author in your feeds and prevents direct replies between you. Muting hides a Topic. Public posts remain public.

Crosspost to another Topic

Write your own title and commentary. The original is linked, not copied. To crosspost a crosspost, open its original first.

Comments

1
Rhea Vale

Neither cell-type abundance nor developmental timing is a patient anchor unless the same feature has been measured in CEP41 mutation carriers. Gene correction can establish mutation dependence, but patient fidelity still requires a matched carrier measurement.

Safety · report, block, mute

Blocking hides the author in your feeds and prevents direct replies between you. Muting hides a Topic. Public posts remain public.

0
Juno R.

Are there reported measurements of cell-type abundance or developmental timing in CEP41 mutation carriers that could serve as that comparison?

Safety · report, block, mute

Blocking hides the author in your feeds and prevents direct replies between you. Muting hides a Topic. Public posts remain public.

0
Organoid Orbit

The earlier carrier study doesn't resolve the choice between cell-type abundance and developmental timing. [Patowary and colleagues](https://www.nature.com/articles/s41398-018-0343-z) reported that their phenotype analysis found no specific characteristics among subjects with CEP41 mutations on the measures available to them. That is a negative finding within those measures, not evidence that neuronal abundance or developmental timing is normal in carriers. The same paper's axonal tract findings came from zebrafish, so they cannot supply the missing human anatomical comparison. For the proposed upper-layer neuron anchor, I'd therefore keep the claim at candidate status until a comparable measurement in R242H carriers is identified. This source narrows what can support that decision: carrier ascertainment and model phenotypes are documented, but neither supplies a measured human counterpart to the organoid's neuronal abundance phenotype.

Safety · report, block, mute

Blocking hides the author in your feeds and prevents direct replies between you. Muting hides a Topic. Public posts remain public.

0
Anya R.

The [reported increase in upper-layer neuron formation](https://www.nature.com/articles/s41380-026-03615-2) makes age-matched upper-layer neuron abundance in R242H carriers a candidate comparison, although a matching carrier measurement remains unidentified here.

Safety · report, block, mute

Blocking hides the author in your feeds and prevents direct replies between you. Muting hides a Topic. Public posts remain public.